• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】27521

【品名】(2R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]propanal

【CA登记号】

【 分 子 式 】C34H60O3Si2

【 分 子 量 】573.0196

【元素组成】C 71.27% H 10.55% O 8.38% Si 9.8%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(I)

Reduction of vitamin D derivative (I) with NaBH4 in ethanol-THF affords alcohol (II), which is alkylated with propargyl bromide (III) and potassium tert-butoxide in the presence of a crown ether. The resulting propargyl ether (IV) is condensed with hexafluoroacetone, by means of butyl litium, to provide tertiary alcohol (V). This compound is then photochemically isomerized in the presence of anthracene as a sensitizer to give (VI). Final deprotection of TBDMS groups with tetrabutylammonium fluoride in THF yields the title compound.

1 Calverley, M.J.; Grue-Sorensen, G.; Binderup, E.T. (Leo Pharmaceutical Products Ltd. A/S); Novel vitamin D analogues. EP 0522013; JP 1993505613; US 5374629; WO 9115475 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27521 (2R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]propanal C34H60O3Si2 详情 详情
(II) 27522 (2R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-propanol C34H62O3Si2 详情 详情
(III) 11176 3-Bromopropyne; 3-Bromo-1-propyne 106-96-7 C3H3Br 详情 详情
(IV) 27523 (1R,5S)-3-((E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(1R)-1-methyl-2-(2-propynyloxy)ethyl]octahydro-4H-inden-4-ylidene]ethylidene)-5-[[tert-butyl(dimethyl)silyl]oxy]-4-methylenecyclohexyl tert-butyl(dimethyl)silyl ether C37H64O3Si2 详情 详情
(V) 27524 5-[((2R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]propyl)oxy]-1,1,1-trifluoro-2-(trifluoromethyl)-3-pentyn-2-ol C40H64F6O4Si2 详情 详情
(VI) 27525 5-[((2R)-2-[(1R,3aS,7aR)-4-[(Z)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]propyl)oxy]-1,1,1-trifluoro-2-(trifluoromethyl)-3-pentyn-2-ol C40H64F6O4Si2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

Vitamin D derivative (I) was condensed with ethyllithium al low temperature to give, after chromatographic separation of isomers, alcohol (II). Alkylation of (II) with 6-bromo-3-ethyl-3-(trimethylsilyloxy)hexane (III) and potassium tert-butoxide in the presence of a crown ether afforded ether (IV), which was then photochemically isomerized in the presence of anthracene as a sensitizer to give (V). Final deprotection of silyl groups of (V) with 5% hydrogen fluoride in ethyl acetate-acetonitrile yielded the title compound.

1 Calverley, M.J.; Grue-Sorensen, G.; Binderup, E.T. (Leo Pharmaceutical Products Ltd. A/S); Novel vitamin D analogues. EP 0522013; JP 1993505613; US 5374629; WO 9115475 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27521 (2R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]propanal C34H60O3Si2 详情 详情
(II) 27526 (2R,3R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]-3-pentanol C36H66O3Si2 详情 详情
(III) 14241 (5-Bromo-2,2-diethylpentyl)(trimethyl)silane C12H27BrSi 详情 详情
(IV) 27527 [5-[((1R,2R)-2-[(1R,3aS,7aR)-4-[(E)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-ethylpropyl)oxy]-2,2-diethylpentyl](trimethyl)silane C48H92O3Si3 详情 详情
(V) 27528 (1R,2R)-2-[(1R,3aS,7aR)-4-[(Z)-2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-ethylpropyl 4-ethyl-4-[(trimethylsilyl)methyl]hexyl ether C48H92O3Si3 详情 详情
Extended Information